These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 31406106

  • 21. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells.
    Kim SY, Hwangbo H, Kim MY, Ji SY, Lee H, Kim GY, Kwon CY, Leem SH, Hong SH, Cheong J, Choi YH.
    Arch Biochem Biophys; 2021 Jan 15; 697():108688. PubMed ID: 33227289
    [Abstract] [Full Text] [Related]

  • 22. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
    Wang SS, Chen YH, Chen N, Wang LJ, Chen DX, Weng HL, Dooley S, Ding HG.
    Cell Death Dis; 2017 Mar 23; 8(3):e2688. PubMed ID: 28333142
    [Abstract] [Full Text] [Related]

  • 23. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis.
    Liu X, Gao X, Yang Y, Yang D, Guo Q, Li L, Liu S, Cong W, Lu S, Hou L, Wang B, Li N.
    Apoptosis; 2024 Aug 23; 29(7-8):1161-1184. PubMed ID: 38743191
    [Abstract] [Full Text] [Related]

  • 24. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H.
    Mol Cancer; 2018 Aug 08; 17(1):117. PubMed ID: 30089483
    [Abstract] [Full Text] [Related]

  • 25. Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.
    Wang X, Han L, Zhang J, Xia Q.
    Dig Dis Sci; 2015 Oct 08; 60(10):3011-8. PubMed ID: 26055238
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr 08; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 27. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 08; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 28. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM, Wu QM, Chang LY, Liu JC.
    Neoplasma; 2020 Sep 08; 67(5):1042-1053. PubMed ID: 32484698
    [Abstract] [Full Text] [Related]

  • 29. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H, Zhang C, Xu L, Zang K, Ning Z, Jiang F, Chi H, Zhu X, Meng Z.
    Oncotarget; 2016 Apr 12; 7(15):20193-208. PubMed ID: 26958938
    [Abstract] [Full Text] [Related]

  • 30. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
    Wei H, Hu J, Pu J, Tang Q, Li W, Ma R, Xu Z, Tan C, Yao T, Wu X, Long X, Wang J.
    Int Immunopharmacol; 2019 Aug 12; 73():72-80. PubMed ID: 31082725
    [Abstract] [Full Text] [Related]

  • 31. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
    Ni Q, Chen Z, Zheng Q, Xie D, Li JJ, Cheng S, Ma X.
    Cancer Sci; 2020 May 12; 111(5):1500-1513. PubMed ID: 31997489
    [Abstract] [Full Text] [Related]

  • 32. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, Yang XR, Guo W.
    J Hematol Oncol; 2019 Apr 11; 12(1):37. PubMed ID: 30971294
    [Abstract] [Full Text] [Related]

  • 33. LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway.
    Pu Z, Wu L, Guo Y, Li G, Xiang M, Liu L, Zhan H, Zhou X, Tan H.
    J Cell Biochem; 2019 Oct 11; 120(10):18172-18185. PubMed ID: 31144362
    [Abstract] [Full Text] [Related]

  • 34. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway.
    Li TT, Zhu D, Mou T, Guo Z, Pu JL, Chen QS, Wei XF, Wu ZJ.
    Mol Immunol; 2017 Jul 11; 87():132-140. PubMed ID: 28433890
    [Abstract] [Full Text] [Related]

  • 35. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.
    Ye R, Dai N, He Q, Guo P, Xiang Y, Zhang Q, Hong Z, Zhang Q.
    Biomed Pharmacother; 2018 Sep 11; 105():962-973. PubMed ID: 30021391
    [Abstract] [Full Text] [Related]

  • 36. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J, Zhai DS, Huang Q, Chen HL, Zhang Z, Tan QF.
    Eur Rev Med Pharmacol Sci; 2019 Jul 11; 23(14):6091-6104. PubMed ID: 31364110
    [Abstract] [Full Text] [Related]

  • 37. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L, Zheng J, Chen P, Liu Q, Yuan Y.
    Biomed Pharmacother; 2017 Jun 11; 90():705-712. PubMed ID: 28419966
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J, Pi C, Wang G.
    Biomed Pharmacother; 2018 Jul 11; 103():699-707. PubMed ID: 29680738
    [Abstract] [Full Text] [Related]

  • 39. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling.
    Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J.
    Cancer Sci; 2018 May 11; 109(5):1414-1427. PubMed ID: 29603830
    [Abstract] [Full Text] [Related]

  • 40. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
    Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB.
    Cancer Med; 2020 Sep 11; 9(17):6399-6410. PubMed ID: 32691991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.